Kerala Ayurveda Results Update

Kerala Ayurveda Board Meeting Date

Kerala Ayurveda has given prior intimation of a board meeting on 12 November 2026 to consider unaudited standalone and consolidated half-year results for September 2026. Trading window closes from 30 September 2026 until 48 hours after results are declared.

Kerala Ayurveda Capital Structure Change

Kerala Ayurveda's board approved allotment of 6,55,000 equity shares at Rs.190.37 to promoter-group entity Katra Holding, settled by adjusting an unsecured loan. This is a capital structure change, with corporate action still pending.

Value

₹124.7 Cr

Kerala Ayurveda Preferential Issue

Kerala Ayurveda allotted 6,55,000 preferential shares to Katra Holding at Rs. 190.37 each, totaling Rs. 12.47 Crore. The existing unsecured loan was adjusted as consideration.

Value

₹12.47 Cr

Kerala Ayurveda Other Announcement

Kerala Ayurveda Ltd has filed its quarterly shareholding pattern report for the period ended September 30, 2026, as required by SEBI regulations.

Kerala Ayurveda Annual General Meeting

Kerala Ayurveda Ltd held its 34th Annual General Meeting on September 28, 2026, where shareholders discussed financial statements, director re-appointment, and preferential share issuance.

Kerala Ayurveda Capital Structure Change

Kerala Ayurveda Ltd revised its preferential issue, reducing the offer size to 6,55,000 equity shares at Rs. 190.37 each, totaling Rs. 12.47 Crore.

Value

₹12.47 Cr

Mukka Proteins Results Update

Mukka Proteins reported Q2 FY27 revenue up 108% YoY to Rs.5,088.70 Mn. The Oman facility began commercial production, adding 37,200 MTPA of capacity.

Oman facility manufacturing capacity

37200.0 MTPA

Aztec Fluids & Machinery Results Update

Aztec Fluids reported H1 FY27 consolidated revenue of Rs.53.88 crore, up 10.1%, with PAT of Rs.3.58 crore. The release also covers cash flow, balance sheet metrics and the AZTRACE traceability platform.

Ramky Infrastructure Results Update

Ramky Infrastructure's press release reports Q2 FY27 consolidated revenue up 28% and PAT up 36%. Half-year consolidated PAT fell 7%, while standalone PAT rose 21%.

Striders Impex Results Update

Striders Impex's H1 FY27 revenue rose 50.5% to ₹39.2 crore, yet EBITDA fell 35.9% to ₹1.6 crore. Profit after tax dropped to ₹0.8 crore on higher costs.

Jaro Institute of Technology Management and Research Results Update

Jaro Education's press release reports H1 FY27 PAT up 21% and Total Income up 15%. New academic and corporate partnerships were also announced.

Tata Chemicals Results Update

Tata Chemicals' Q2FY27 standalone revenue rose 8% to ₹1,303 Cr, with EBITDA up 22%. Consolidated results show a ₹50 Cr loss after tax amid soda ash pricing pressure.